JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gollasch, M.
Right arrow Articles by Haller, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gollasch, M.
Right arrow Articles by Haller, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*POTASSIUM

Pinacidil relaxes porcine and human coronary arteries by activating ATP- dependent potassium channels in smooth muscle cells

M Gollasch, R Bychkov, C Ried, F Behrendt, S Scholze, FC Luft and H Haller

Franz Volhard Clinic, Rudolf Virchow University Hospitals, Berlin, Germany.

We investigated the effect of the potassium channel opener pinacidil on ATP-dependent K+ channels (KATP) in the relaxation of porcine and human coronary arteries by means of isometric contraction experiments in arterial rings. We also measured whole cell currents in freshly isolated porcine and human coronary artery vascular smooth muscle cells with patch clamp. We first characterized serotonin-induced precontractions in our vessels and proved that the contractions were mediated by Ca2+ influx through voltage-dependent Ca2+ channels. Similarly, we observed that serotonin-induced contractions were strongly enhanced by small K(+)-induced depolarizations. Pinacidil completely relaxed rings preconstricted with 5 microM serotonin and produced dose-dependent relaxations of 5 microM serotonin- preconstricted rings, with an IC50 of 1.26 microM. Similar results were observed (IC50 = 1.15 microM) when the endothelium was removed. The KATP blocker glibenclamide (3 microM), inhibited pinacidil-induced relaxations (5-10 microM) by approximately 25% although the KATP blocker tetrapentylammonium (10 microM), inhibited pinacidil-induced (5- 10 microM) relaxations completely. Pinacidil 10 microM had only a minimal effect on rings precontracted with a 50 mM external K+ concentration (IC50 = 60 microM). Porcine and human arterial rings did not differ qualitatively in their responses. Moreover, in the patch clamp experiments pinacidil (1 microM and 20 microM) induced a large, nonrectifying, outward current in both human and porcine cells. The reversal potential was close to the K+ equilibrium potential, suggesting an induction of pinacidil-activated K+ current. The pinacidil-induced (1 microM) current was strongly inhibited by glibenclamide (3 microM). These data show that the relaxation of porcine and human coronary arteries by pinacidil is primarily induced by an opening of KATP in smooth muscle cells. Furthermore, the vasorelaxant effect of pinacidil is not endothelium dependent.

Volume 275, Issue 2, pp. 681-692, 11/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Y.-J. Gao, K. Takemori, L.-Y. Su, W.-S. An, C. Lu, A. M. Sharma, and R. M.K.W. Lee
Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion
Cardiovasc Res, July 15, 2006; 71(2): 363 - 373.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. M. O. Farouque and I. T. Meredith
Relative contribution of vasodilator prostanoids, NO, and KATP channels to human forearm metabolic vasodilation
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2405 - H2411.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Miura, R. E. Wachtel, F. R. Loberiza Jr, T. Saito, M. Miura, A. C. Nicolosi, and D. D. Gutterman
Diabetes Mellitus Impairs Vasodilation to Hypoxia in Human Coronary Arterioles: Reduced Activity of ATP-Sensitive Potassium Channels
Circ. Res., February 7, 2003; 92(2): 151 - 158.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. LOHN, G. DUBROVSKA, B. LAUTERBACH, F. C. LUFT, M. GOLLASCH, and A. M. SHARMA
Periadventitial fat releases a vascular relaxing factor
FASEB J, July 1, 2002; 16(9): 1057 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. M. Jayawant and R. J. Damiano Jr
The superiority of pinacidil over adenosine cardioplegia in blood-perfused isolated hearts
Ann. Thorac. Surg., October 1, 1998; 66(4): 1329 - 1335.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Jayawant, E. R. Stephenson Jr., and R. J. Damiano Jr.
Advantages of continuous hyperpolarized arrest with pinacidil over St. Thomas' hospital solution during prolonged ischemia
J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 131 - 138.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Bychkov, M. Gollasch, T. Steinke, C. Ried, F. C. Luft, and H. Haller
Calcium-Activated Potassium Channels and Nitrate-Induced Vasodilation in Human Coronary Arteries
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 293 - 298.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Bychkov, M. Gollasch, C. Ried, F. C. Luft, and H. Haller
Regulation of Spontaneous Transient Outward Potassium Currents in Human Coronary Arteries
Circulation, January 21, 1997; 95(2): 503 - 510.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M. Gollasch, C. Ried, R. Bychkov, F. C. Luft, and H. Haller
K+ Currents in Human Coronary Artery Vascular Smooth Muscle Cells
Circ. Res., April 1, 1996; 78(4): 676 - 688.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics.